Aquestive Therapeutics (AQST) Total Current Liabilities (2017 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Total Current Liabilities of $31.8 million for Q1 2026, up 73.53% year-over-year from $18.3 million in Q1 2025, and down 33.3% quarter-over-quarter from $47.6 million in Q4 2025.
Aquestive Therapeutics (AQST) Total Current Liabilities (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' Total Current Liabilities history runs 10 years deep, the most recent figure standing at $31.8 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 73.53% year-over-year to $31.8 million; the TTM figure through Mar 2026 stood at $31.8 million (up 73.53% YoY), while the FY2025 annual figure was $47.6 million, up 152.36% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $31.8 million, down from $47.6 million in the prior quarter.
- The five-year high for Total Current Liabilities was $47.6 million in Q4 2025, with the low at $13.9 million in Q2 2024.
- The 5-year median for Total Current Liabilities is $24.2 million (2022), against an average of $27.3 million.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities tumbled 64.05% in 2024, then soared 152.36% in 2025.
- Aquestive Therapeutics' Total Current Liabilities stood at $39.5 million in 2022, then sank by 53.68% to $18.3 million in 2023, then grew by 3.04% to $18.9 million in 2024, then jumped by 152.36% to $47.6 million in 2025, then tumbled by 33.3% to $31.8 million in 2026.
- Business Quant data shows AQST's Total Current Liabilities at $31.8 million in Q1 2026, $47.6 million in Q4 2025, and $25.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 1.79 Bn |
| 10 | Aquestive Therapeutics | 554.85 Mn | 554.85 Mn | 9.80 Mn | 16.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.48 Mn |
| Mar 31, 2026 | 31.75 Mn |
| Dec 31, 2025 | 47.61 Mn |
| Sep 30, 2025 | 25.57 Mn |
| Jun 30, 2025 | 23.16 Mn |
| Mar 31, 2025 | 18.30 Mn |
| Dec 31, 2024 | 18.87 Mn |
| Sep 30, 2024 | 15.15 Mn |
| Jun 30, 2024 | 13.90 Mn |
| Mar 31, 2024 | 18.06 Mn |
| Dec 31, 2023 | 18.31 Mn |
| Sep 30, 2023 | 24.06 Mn |
| Jun 30, 2023 | 38.65 Mn |
| Mar 31, 2023 | 40.38 Mn |
| Dec 31, 2022 | 39.53 Mn |
| Sep 30, 2022 | 36.56 Mn |
| Jun 30, 2022 | 29.64 Mn |
| Mar 31, 2022 | 24.18 Mn |
| Dec 31, 2021 | 21.96 Mn |
| Sep 30, 2021 | 25.04 Mn |